- Lobbying
- Ken AND Ackerman
Lobbying Arrangements Results for 'Ken Ackerman'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Advise, consult and advocate on issues and programs related to biofuel production. |
Fulcrum BioEnergy, Inc.
|
Olsson Frank Weeda Terman Matz PC | |||
Details Provide advocacy services and representation involving agriculture risk management. Consulting regarding livestock insurance and other agricultural issues. |
Watts and Associates
|
Olsson, Frank, Weeda, Terman & Matz, PC | |||
Details Promotion of Farmer Mac interests relating to 2012 Farm Bill |
Farmer Mac
|
Olsson Frank Weeda Terman Matz PC | |||
Details Support for BCAP |
Crowell and Moring/BCAP
|
Olsson Frank Weeda Terman Matz PC | |||
Details Advise and consult on issues related to Indian issues |
LOWER BRULE SIOUX TRIBE
|
Olsson, Frank, Weeda, Terman & Matz, PC | |||
Details provide monitoring, consulting and advocacy service regarding legislation relating to the areas geospatial data |
National Geospatial Coalition
|
Olsson, Frank, Weeda, Terman & Matz, PC | |||
Details Consult and advocate regarding use of geospatial imaging in federal agriculture programs |
Agriculture Geospatial Coalition, LLC
|
Olsson Frank Weeda Terman Matz PC | |||
Details Provide lobbying and consulting services regarding the 2008 Farm Bill implementation and the Federal Sugar Program; Provide lobbying and consulting services regarding agriculture provisions of clim... |
SOUTHERN MINNESOTA BEET SUGAR COOPERATIVE
|
Olsson Frank Weeda Terman Matz PC | |||
Details Enhancements to Farmer Mac's lending authorities in the farm bill reauthorization including elimination of the 2000-acre limitation, elimination of the cooperative lender origination requirement fo... |
Federal Agricultural Mortgage Corporation
|
in-house lobbying | |||
Details Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S... |
Novo Nordisk Inc.
|
DLA Piper LLP (US) |